Pain News and Research

Latest Pain News and Research

Study finds several osteoporosis risk factors among post-menopausal women on HRT

A preliminary study of 127 post-menopausal women on hormone replacement therapy in Portugal suggests that there are several risk factors associated with osteoporosis and bone fracture these include age, low bone mineral density, a sedentary lifestyle, coffee consumption and ovariectomy. Details are reported later this month in the International Journal of Medical Engineering and Informatics.

14 Nov 2012

Reflexology can help cancer patients manage their symptoms and perform daily tasks

A study led by a Michigan State University researcher offers the strongest evidence yet that reflexology - a type of specialized foot massage practiced since the age of pharaohs - can help cancer patients manage their symptoms and perform daily tasks.

14 Nov 2012

$Increased dairy food consumption helps to prevent hip fractures and reduce healthcare costs$

Increased dairy food consumption helps to prevent hip fractures and reduce healthcare costs

European researchers have published a study which analyses the health economics of increased dairy foods and related reduction in risk of osteoporotic fractures in the population aged over 50.

14 Nov 2012

AspenBio Pharma provides clinical and business update for third quarter 2012

AspenBio Pharma, Inc., an in vitro diagnostic company, today provided a clinical and business update for the third quarter 2012. The Company reported it has started the hospital training phase of its pivotal U.S. clinical study and remains on track to initiate patient enrollment before the end of the year.

13 Nov 2012

Novel electrotherapy reduces energy needed to re-establish normal rhythm in the heart

Implantable defibrillators currently on the market apply between 600 and 900 volts to the heart, almost 10 times the voltage from an electric outlet, says Ajit H. Janardhan, MD, PhD, a cardiac electrophysiology fellow at the Washington University's School of Medicine.

13 Nov 2012

Women with migraines do not appear to experience cognitive decline

Women with migraines did not appear to experience a decline in cognitive ability over time compared to those who didn't have them, according to a nine-year follow up study funded by the National Institutes of Health.

13 Nov 2012

Human models could be way forward for assessing analgesic efficacy

Researchers say that human experimental pain models could be used to assess the clinical efficacy of analgesics in phase I clinical studies.

13 Nov 2012

Multimodal approach relieves obstetric back and pelvic pain

Pregnant women with low-back pain and pelvic pain could benefit from a multimodal approach of musculoskeletal and obstetric management, say researchers.

13 Nov 2012

Tolvaptan improves kidney health in polycystic kidney disease

A vasopressin V2-receptor blocker slows the increase in total kidney volume and decline in kidney function in patients with autosomal dominant polycystic kidney disease, report US researchers.

12 Nov 2012

Mastoscopic axillary lymph node dissection ‘preferred choice’

Long-term study findings support the use of mastoscopic axillary lymph node dissection for women with operable breast cancer.

12 Nov 2012

Auto-injector developed for women undergoing fertility treatment

A new auto-injector concept has been designed by innovative product development firm Cambridge Consultants in a bid to ease the trauma for women undergoing fertility treatment.

12 Nov 2012

Tips to stay safe during cold-weather months

With temperatures falling into the 30s this week, people will be turning up the heat to stay warm. But, as the temperature drops, the number of patients treated by the Vanderbilt Regional Burn Center typically increases due to unsafe heating methods that result in injury.

9 Nov 2012

Omeros to present results from first pivotal Phase 3 trial of OMS302 at AAO annual meeting

Omeros Corporation today reported that it will present data from its first pivotal Phase 3 clinical trial evaluating OMS302 at the American Academy of Ophthalmology (AAO) Annual Meeting, which will take place from November 10 through November 13 in Chicago, Illinois.

9 Nov 2012

Mastoscopic axillary lymph node dissection can reduce breast cancer complications

Axillary lymph node dissection is done in conjunction with lumpectomy or mastectomy to determine if breast cancer has spread to the adjoining lymph nodes. The conventional surgical approach leaves a surgical scar that is unattractive and can restrict range of motion in the shoulder joint. Also, squeezing and pulling the tumor during the breast operation can stimulate tumor cell metastases.

9 Nov 2012

Positive results from Palatin’s bremelanotide Phase 2B trial on female sexual dysfunction

Palatin Technologies, Inc. today reported positive top-line results, including the successful achievement of statistical significance for the primary endpoint and key secondary endpoints in its Phase 2B clinical trial evaluating the efficacy and safety of bremelanotide for the treatment of female sexual dysfunction (FSD).

9 Nov 2012

Avinger receives FDA clearance for Ocelot System

Avinger, Inc., a medical device manufacturer of innovative, multi-functional catheters for crossing chronic total occlusions (CTOs) in patients with Peripheral Artery Disease (PAD), announces its Ocelot System has been cleared for sale in the U.S. by the Food and Drug Administration (FDA).

9 Nov 2012

Plexxikon updates Zelboraf Phase 1 data on BRAF V600E mutation-positive melanoma

Plexxikon today announced that updated Phase 1 clinical data of Zelboraf (vemurafenib) were presented at the Society for Melanoma Research (SMR) 2012 Congress, held November 8-11 in Los Angeles, CA.

8 Nov 2012

Low antioxidant levels contribute to increased blood pressure during exercise for people with PAD

Low antioxidant levels contribute to increased blood pressure during exercise for people with peripheral arterial disease, according to researchers at Penn State Hershey Heart and Vascular Institute.

8 Nov 2012

Soligenix receives FDA Fast Track designation for SGX203 to treat pediatric Crohn's disease

Soligenix, Inc., a development stage biopharmaceutical company, announced today that its program for development of SGX203 (oral beclomethasone 17,21-dipropionate or oral BDP) for the induction treatment of mild-to-moderate pediatric Crohn's disease has received "Fast Track" designation from the U.S. Food and Drug Administration (FDA).

8 Nov 2012

Two-drug combo relieves agitation first time

The majority of advanced cancer patients who experience agitation achieve control after the first dose of an antipsychotic–antiseizure combination is administered, show study results.

8 Nov 2012

Pain News and Research

Latest Pain News and Research

Study finds several osteoporosis risk factors among post-menopausal women on HRT

Reflexology can help cancer patients manage their symptoms and perform daily tasks

Increased dairy food consumption helps to prevent hip fractures and reduce healthcare costs

AspenBio Pharma provides clinical and business update for third quarter 2012

Novel electrotherapy reduces energy needed to re-establish normal rhythm in the heart

Women with migraines do not appear to experience cognitive decline

Human models could be way forward for assessing analgesic efficacy

Multimodal approach relieves obstetric back and pelvic pain

Tolvaptan improves kidney health in polycystic kidney disease

Mastoscopic axillary lymph node dissection ‘preferred choice’

Auto-injector developed for women undergoing fertility treatment

Tips to stay safe during cold-weather months

Omeros to present results from first pivotal Phase 3 trial of OMS302 at AAO annual meeting

Mastoscopic axillary lymph node dissection can reduce breast cancer complications

Positive results from Palatin’s bremelanotide Phase 2B trial on female sexual dysfunction

Avinger receives FDA clearance for Ocelot System

Plexxikon updates Zelboraf Phase 1 data on BRAF V600E mutation-positive melanoma

Low antioxidant levels contribute to increased blood pressure during exercise for people with PAD

Soligenix receives FDA Fast Track designation for SGX203 to treat pediatric Crohn's disease

Two-drug combo relieves agitation first time

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

Pain News and Research

Latest Pain News and Research

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

Newsletters you may be interested in